Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination with Metformin IR or Metformin XR in Pediatric Patients with Type 2 Diabetes

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date10/31/11 → 10/30/14

Funding

  • Bristol Myers Squibb Company: $4,706.00